Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
12/2001
12/04/2001US6326394 Calixarene tubes as cation receptors
12/04/2001US6326380 Thrombin receptor antagonists
11/2001
11/28/2001EP1157992A1 Dihydro-2,3-Benzodiazepine derivatives
11/28/2001EP1157023A1 C-21 modified epothilones
11/28/2001EP1156801A1 Compounds and methods
11/28/2001EP0907647B1 Crown calix (4)arenes, method of preparation and use for selective extraction of caesium
11/28/2001EP0770068B1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents
11/28/2001CN1324355A Oxobenzofuranylide-dihydroindolone
11/27/2001US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/22/2001WO2001005769A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
11/22/2001US20010044547 From l-mannonic-gamma-lactone intermediates; for prophylaxis of HIV/AIDS HIV
11/21/2001CN1323287A Process for making aromatic aldehydes
11/21/2001CN1323286A Process for making aromatic aldehydes using ionic liquids
11/21/2001CN1075105C Polymerizable chiral compound and use thereof
11/21/2001CN1074927C Active medical component of 'Duanshepiju' its extraction process and medicine containing the same
11/20/2001US6320083 Reacting alkyl aromatic compound with carbon monoxide in presence of acidic ionic liquid to form alkyl aromatic aldehyde
11/20/2001US6319946 Inhibitors of aspartyl protease
11/20/2001US6319929 Suksdorfin analogs, compositions thereof, and methods for making and using thereof
11/20/2001CA2024843C Synthesis of mannojirimycin derivatives
11/20/2001CA2012507C Non-migrating 1-hydrocarbyloxy hindered amine compounds as polymer stabilizers
11/15/2001WO2001085218A2 Acylated cyclodextrin guest inclusion complexes
11/15/2001WO2001014339A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
11/15/2001WO2000044216A8 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis
11/15/2001US20010041796 Taxol derivative; antitumor agents
11/15/2001DE19954230A1 New, chemically and metabolically stable 16-halo or cyano-epothilone derivatives are cell division regulators useful e.g. for treating malignant tumors or chronic inflammatory disease
11/14/2001CN1322205A Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
11/13/2001US6316630 Treating epothilone to deoxygenate the epothilone, and thereby to provide the desoxyepothilone
11/13/2001US6316491 Radicicol derivatives
11/13/2001US6316486 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/13/2001US6315928 For ophthalmic lenses
11/08/2001WO2001083500A1 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests
11/08/2001WO2001083488A1 Improved synthesis of anhydroglycitol esters of improved colour
11/08/2001WO2001083476A1 Chromenylmethyl pyrimidinediamines as antibacterial agents
11/08/2001CA2407611A1 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests
11/08/2001CA2405614A1 Chromenylmethyl pyrimidinediamines as antibacterial agents
11/07/2001EP1151295A1 Methods of identifying therapeutically effective antineoplastic agents with cultured cells having intact cell membranes and corresponding products
11/07/2001EP1150984A1 Artemisinin analogs having antimalarial, antiproliferative, and antitumor activities and chemoselective methods of making the same
11/07/2001EP1150980A2 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
11/07/2001CN1074414C indolylalkyl derivs. of benzodioxanmethylamine as 5-HT1A receptor ligands
11/06/2001US6313326 Compounds and their application as well as a method of producing liquid crystalline polymers therefrom
11/06/2001US6313320 Process for the preparation of calanolide precursors
11/06/2001US6313204 Heating and melting a resin formulation comprising polyolefin resin, nucleating agent containing diacetal compound to give molten resin in which nucleating agent is uniformly dissolved; cooling
11/06/2001US6313160 Substituted heterocyclic compounds, method for preparing and compositions containing same
11/01/2001WO2001081351A1 Fluorescent compounds
11/01/2001WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
11/01/2001WO2001081341A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
11/01/2001WO2001081338A1 Substituted sulfonylaminopyrimidines
11/01/2001WO2001030736A3 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors
11/01/2001WO2000039276A9 Microbial transformation method for the preparation of an epothilone
11/01/2001US20010036652 Diels-Alder process; antitumor agents
11/01/2001CA2407641A1 Fluorescent compounds
10/2001
10/31/2001EP1043988A4 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities
10/31/2001CN1073996C Crystalline form of dihydro-2,3-benzodiazepine derivative
10/31/2001CN1073995C Physical form of dihydro-2,3-benzodiazepine derivative
10/31/2001CN1073825C Food composition containing balancing agent for omega'-6-and'omega'-3 unsaturated fatty acids
10/30/2001US6309881 Aldehyde and ketone reactants are contacted with antibody molecules or molecules containing antibody combining site portions that catalyze an aldol addition reaction
10/30/2001US6309687 Anti-first-pass effect compounds
10/30/2001CA2029863C Compositions and methods for treating viral infections
10/25/2001WO2001079247A1 Novel discalamide compounds and their use as anti-proliferative agents
10/25/2001WO2001079246A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/25/2001WO2001079203A1 Herbicidal 3-heterocyclic substituted benzisothiazole and benzisoxazole compounds
10/25/2001WO2000056737A9 Calanolides for inhibiting btk
10/25/2001WO2000054768A9 Anti-first-pass effect compounds
10/25/2001US20010034452 Epothilons C and D, preparation and compositions
10/25/2001US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
10/25/2001DE10020899A1 New 9-oxa-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease
10/25/2001DE10020517A1 New 13-halo or cyano-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease
10/25/2001CA2408396A1 Herbicidal 3-heterocyclic substituted benzisothiazole and benzisoxazole compounds
10/25/2001CA2404639A1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/24/2001CN1073562C Method for extracting material containing raw anthocyanidin from ginkgo leaf by supercritical carbon dioxide
10/23/2001US6307068 Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
10/23/2001US6307057 Catalyze enantioselective reactions, e.g., diels-alder reactions
10/23/2001US6306899 Viricides
10/23/2001US6306897 Calanolides for inhibiting BTK
10/23/2001US6306896 Pharmaceutically active composition containing artemisinine and/or derivative of artemisinine
10/23/2001US6306587 Template-directed photoligation
10/23/2001CA2037411C Milbemycin ether derivatives
10/18/2001WO2001078162A2 Oligomeric and polymeric oled materials produced via arylation of quinones
10/17/2001EP1144417A1 4'-substituted-4',5'-dihydropsoralens and therapeutical uses thereof
10/17/2001EP1144416A1 Heterocyclically anellated indenochromene derivatives
10/17/2001EP1144390A2 Kinase inhibitors
10/17/2001EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001CN1317937A Compsn. containing natural phenolic compound for preventing or treating elevated blood liquid level-related diseases
10/16/2001US6303827 Process for making aromatic aldehydes
10/16/2001US6303789 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
10/16/2001US6303342 Recombinant methods and materials for producing epothilones C and D
10/11/2001WO2001074798A1 Reworkable composition of oxirane(s) or thiirane(s)-containing resin and curing agent
10/11/2001WO2001074741A2 Catalytic asymmetric desymmetrization of meso compounds
10/11/2001US20010029303 Total synthesis of antitumor acylfulvenes
10/11/2001US20010029265 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
10/11/2001DE10015836A1 New epothilone derivatives used for treating e.g. malignant melanoma, breast carcinoma, psoriasis, multiple sclerosis and arthritis
10/11/2001CA2405535A1 Catalytic asymmetric desymmetrization of meso compounds
10/11/2001CA2403595A1 Reworkable composition of oxirane(s) or thiirane(s)-containing resin and curing agent
10/10/2001EP1140944A1 Epothilone derivatives and their use as antitumor agents
10/10/2001EP1140928A2 Microbial transformation method for the preparation of an epothilone
10/10/2001EP1140888A1 Optical molecular sensors for cytochrome p450 activity
10/10/2001EP1140884A1 Process for production of an oxetane
10/10/2001EP1140811A1 Novel herbicides
10/10/2001EP1140733A1 Process and products of purification of anhydrosugar alcohols
10/10/2001EP1140069A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR